ductus arteriosus Am J Cardiol 1996;77:209– 211 155 Moore JW, Schneider DJ, DiMeglio D The Duct-occlud device: design, clinical results, and future directions J Intervent Cardiol 2001;14:231–238 156 Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE Multicenter USA amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results J Am Coll Cardiol 2004;44:513–519 157 Masura J, Gavora P, Podnar T Transcatheter occlusion of patent ductus arteriosus using a new angled amplatzer duct occluder: initial clinical experience Catheter Cardiovasc Interv 2003;58:261–267 158 Sideris EB, Rao PS Sideris’ buttoned device for transcatheter closure of patent ductus arteriosus J Interv Cardiol 2001;14:239–246 159 Mahmoud HT, Santoro G, Gaio G, et al Singlecenter experience in percutaneous closure of arterial duct with amplatzer duct occluder II additional sizes Catheter Cardiovasc Interv 2017;89:1045–1050 160 Galal MO, Hussain A, Arfi AM Do we need the surgeon to close the persistently patent arterial duct? Cardiol Young 2006;16:522–536 161 Rao PS Summary and comparison of patent ductus arteriosus closure methods Rao PS, Kern MJ Catheter Based Devices for the Treatment of Non-Coronary Cardiovascular Disease in Adults and Children Lippincott Williams & Wilkins: Philadelphia, Pa; 2003:219–228 162 Behjati-Ardakani M, Rafiei M, Behjati-Ardakani MA, Vafaeenasab M, Sarebanhassanabadi M Long-term results of transcatheter closure of patent ductus arteriosus in adolescents and adults with amplatzer duct occluder N Am J Med Sci 2015;7:208–211 163 Forsey JT, Elmasry OA, Martin RP Patent arterial duct Orphanet J Rare Dis 2009;4:17 164 Clyman RL Developmental physiology of the ductus arteriosus Long W Fetal and Neonatal Cardiology WB Saunders: Philadelphia; 1990:64–75 165 Coceani F, White E, Bodach E, Olley PM Agedependent changes in the response of the ductus arteriosus to oxygen and ibuprofen Can J Physiol Pharmacol 1979;57:825–831 166 Clyman RL Ontogeny of the ductus arteriosus response to prostaglandins and inhibitors of their synthesis Semin Perinatol 1980;4:115–124 167 Jacob J, Gluck L, Disessa T, et al The contribution of PDA in the neonate with severe RDS J Pediatr 1980;96:79–87 168 Heymann MA, Hoffman JI Problem of patent ductus arteriosus in premature infants Pediatrician 1978;7:3–17 169 Friedman WF Studies of the response of the ductus arteriosus Heymann MA, Rudolph AM The Ductus Arteriosus Proceedings of the Seventy-Fifth Ross Conference on Pediatric Research 1978:35–43 [Columbus, Ohio] 170 Heymann MA, Rudolph AM Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero Circ Res 1976;38:418–422 171 Mahoney L, Carnero V, Brett C, Heymann MA, Clyman RI Prophylactic indomethacin therapy for patent ductus arteriosus in very low birthweight infants N Engl J Med 1982;306:506–508 172 Mahoney L, Caldwell RL, Girod DA Indomethacin therapy on the first day of life with very low birthweight J Pediatr 1985;106:801–803 173 Cotton RB, Haywood JL, FitzGerald GA Symptomatic patent ductus arteriosus following prophylactic indomethacin A clinical and biochemical appraisal Biol Neonate 1991;60:273–282 ... ductus arteriosus in premature infants Pediatrician 1978;7:3–17 169 Friedman WF Studies of the response of the ductus arteriosus Heymann MA, Rudolph AM The Ductus Arteriosus Proceedings of the Seventy-Fifth Ross Conference on Pediatric. .. 2009;4:17 164 Clyman RL Developmental physiology of the ductus arteriosus Long W Fetal and Neonatal Cardiology WB Saunders: Philadelphia; 1990:64–75 165 Coceani F, White E, Bodach E, Olley PM Agedependent changes in the response of the ductus